Results 241 to 250 of about 136,614 (358)

Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti-HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial. [PDF]

Hepatol Commun
Tabataba Vakili S, Hirode G, Zahoor A, Saunthar A, Feld JB, Hansen BE, Syeda A, Janssen HLA, Kukreti V, Kuruvilla J, Prica A, Cheung M, Buckstein R, Hicks L, Coffin CS, Street LE, Disperati P, Chan KK, Crump M, Feld JJ.   +19 more
europepmc   +1 more source

Efficacy and predictors of pegylated-interferon in hepatitis B surface antigen seroclearance in immune active and inactive chronic hepatitis B patients. [PDF]

J Virus Erad
Han C, Jin L, Zhu M, Qin Q, Li G, Liu Z, Zhang X.   +6 more
europepmc   +1 more source

Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon. [PDF]

Hepatol Int
Dong J, Ren S, Wu P, Yu H, Meng X, Zhao J, Ye X, Huang Y, Yu Z, Zhang W, Zeng Y, Wang X, Gao H, Dang S, Li J, Zheng S, Chen X.   +16 more
europepmc   +1 more source

Prevalence of chronic hepatitis B virus infection and associated factors among pregnant women attending antenatal care at Felege Hiwot Comprehensive Specialized Hospital Ethiopia. [PDF]

Sci Rep
Woreket AA, Tegegne AS, Muhie NS.
europepmc   +1 more source

Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir.

Gastroenterology, 2012
S. Hadziyannis, V. Sevastianos, I. Rapti, D. Vassilopoulos, E. Hadziyannis   +4 more
semanticscholar   +1 more source

Soluble Programmed Cell Death-1: A Potential Predictor of HBsAg Loss in Pediatric Patients with Chronic Hepatitis B Undergoing Peginterferon Therapy. [PDF]

Immunotargets Ther
Yang G, Gan Y, Xia M, Fu Q, Zhang M, Luo K, Wang Z.   +6 more
europepmc   +1 more source

Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial. [PDF]

Gut
Wu X, Quan D, Li W, Wisskirchen K, Wu W, Zhou Y, Liu YP, Wan X, Wang X, Zhang X, Yang L, Zheng M, Zhang K, Protzer U, Du S, Qu X.   +15 more
europepmc   +1 more source

An RNA interference therapeutic potentially achieves functional cure of chronic hepatitis B virus infection. [PDF]

Nat Commun
Huang ZA, Yang Y, Yang S, Ji GS, Fu R, Tian ZK, Wu YC, Song GS.   +7 more
europepmc   +1 more source